Presentation of local and systemic adverse events (AEs) after the first and second dose of BNT162b2 vaccine and median (IQR) SARS-CoV-2 anti-S-RBD antibody titers 3–4 weeks after the second dose (first period) in the study population (n = 439).
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
Presentation of local and systemic adverse events (AEs) after the first and second dose of BNT162b2 vaccine and median (IQR) SARS-CoV-2 anti-S-RBD antibody titers 3–4 weeks after the second dose (first period) in the study population (n = 439).
创建时间：
2022-04-29
